Skip to main content
NIH funding notice PA-19-073

Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)

Closed on January 7, 2022.

Posted
November 20, 2018
Close date
January 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $247,929 in first-year total cost, median $247,929.

Most frequent study sections

  1. Neurological, Aging and Musculoskeletal Epidemiology Study Section[NAME]1

Most frequent institutions

  1. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT1
Competing awards under PA-19-073 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Identifying potentially modifiable exposures to improve telomere health and disease outcomes1R21NR018963-01A1KUO, CHIA-LINGUNIVERSITY OF CONNECTICUT SCH OF MED/DNT, CT$247,929NAME

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.